These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 878299)

  • 1. [Preparation of PMS and biostimulgin].
    Malysheva NI; Dieva VT; Divina EG; Chuklov NF; Mengel' IV
    Veterinariia; 1977 May; (5):76-7. PubMed ID: 878299
    [No Abstract]   [Full Text] [Related]  

  • 2. [PMS and the ways to improve its quality].
    Chuklov NF; Silaev AM; Ubashev AU; Egoshina AA; Kobyl'nikova G
    Veterinariia; 1979 Apr; (4):47. PubMed ID: 156454
    [No Abstract]   [Full Text] [Related]  

  • 3. EEC legislation of medicinal products of biological origin.
    Brunko P; Sauer F
    Dev Biol Stand; 1991; 75():21-5. PubMed ID: 1794622
    [No Abstract]   [Full Text] [Related]  

  • 4. Theoretical considerations on viral inactivation or elimination.
    Willkommen H; Löwer J
    Dev Biol Stand; 1993; 81():109-16. PubMed ID: 8174793
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine contamination of biological products.
    Wadhwa M; Thorpe R
    Biologicals; 1997 Sep; 25(3):307-18. PubMed ID: 9324999
    [No Abstract]   [Full Text] [Related]  

  • 6. Methodological aspects of the validation of purification procedures of human/animal-derived products to remove unconventional slow viruses.
    Pocchiari M
    Dev Biol Stand; 1991; 75():87-95. PubMed ID: 1794633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future development of harmonized guidelines.
    Hayakawa T
    Dev Biol Stand; 1996; 88():331-2. PubMed ID: 9119158
    [No Abstract]   [Full Text] [Related]  

  • 8. Animal virus contaminants of biotechnology products.
    Onions D
    Dev Biol (Basel); 2004; 118():155-63. PubMed ID: 15645686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of a PMS/HCG mixture on gilts depending on the length of storage in mixed state].
    Schlegel W; Heinze A; Wähner M
    Arch Exp Veterinarmed; 1981; 35(4):547-52. PubMed ID: 7347579
    [No Abstract]   [Full Text] [Related]  

  • 10. Problems of contamination, exposure, and pollution in freeze-drying biological products.
    LaSalle B
    Dev Biol Stand; 1976 Oct; 36():201-5. PubMed ID: 1030420
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of neurotropic preparations and PMS to increase fertility in sheep].
    Veliakov SP; Zhirkov GF; Alferov VV; Mangasarov AKh; Kiliazov NI
    Veterinariia; 1966 Oct; 43(10):68-70. PubMed ID: 6002894
    [No Abstract]   [Full Text] [Related]  

  • 12. The hole story. Fine-pore membranes remove viruses from biological drugs.
    Erickson D
    Sci Am; 1992 Sep; 267(3):163-4. PubMed ID: 1502518
    [No Abstract]   [Full Text] [Related]  

  • 13. EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Jul; 19(3):247-51. PubMed ID: 1954007
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the RNA synthesized in the ovary of immature rats after PMS administration.
    Ozaki M; Kubo T; Kim H; Kurachi K
    Acta Obstet Gynaecol Jpn; 1974 Jan; 21(1):49-57. PubMed ID: 4469122
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnant donkey serum gonadotrophin: I--purification and its biological and immunological properties.
    Moodbidri SB; Sheth AR; Rao SS
    Indian J Exp Biol; 1968 Oct; 6(4):216-8. PubMed ID: 4976298
    [No Abstract]   [Full Text] [Related]  

  • 16. Avoiding viral contamination in biotechnological and pharmaceutical processes.
    Henzler HJ; Kaiser K
    Nat Biotechnol; 1998 Nov; 16(11):1077-9. PubMed ID: 9831040
    [No Abstract]   [Full Text] [Related]  

  • 17. European project concerning the guidelines on medicinal products derived from human blood and plasma.
    Horaud F
    Dev Biol Stand; 1991; 75():237-40. PubMed ID: 1794627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At what stage should virus inactivation be carried out?
    Dorner F; Barrett PN; Eibl J
    Dev Biol Stand; 1993; 81():137-43. PubMed ID: 8174796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of administration of thyroxine and PMS hormones on blood corpuscular counts of buffalo bulls (Bubalus bubalis).
    Goswami SB
    Indian Vet J; 1965 Sep; 42(9):670-4. PubMed ID: 5830418
    [No Abstract]   [Full Text] [Related]  

  • 20. [The significance of the luteimizing factor in the hormonal properties of PMS].
    Gorev EL
    Veterinariia; 1966 May; 43(5):70-2. PubMed ID: 6002886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.